SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 118 filers reported holding SYNAGEVA BIOPHARMA CORP in Q2 2014. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $55,791,000 | -29.5% | 572,037 | -32.9% | 0.05% | -32.4% |
| Q4 2014 | $79,136,000 | +39.7% | 852,852 | +3.6% | 0.07% | +30.8% |
| Q3 2014 | $56,640,000 | -30.5% | 823,488 | +5.8% | 0.05% | -30.7% |
| Q2 2014 | $81,546,000 | +18.3% | 778,106 | -6.3% | 0.08% | +17.2% |
| Q1 2014 | $68,913,000 | +1.3% | 830,580 | -21.0% | 0.06% | 0.0% |
| Q4 2013 | $68,003,000 | -13.8% | 1,050,727 | -15.7% | 0.06% | -17.9% |
| Q3 2013 | $78,909,000 | +54.4% | 1,246,390 | +2.4% | 0.08% | +47.2% |
| Q2 2013 | $51,111,000 | – | 1,216,922 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|